SCHEMBL14877980

SCHEMBL14877980

Cc1c(C)c(C)c2c(c(C)cn2C)c1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13444358 0.78 — —
SCHEMBL12055110 0.76 — —
SCHEMBL26539826 0.76 — —
SCHEMBL13444395 0.75 — —
SCHEMBL13444400 0.73 — —
SCHEMBL18165618 0.73 — —
SCHEMBL13444402 0.71 — —
SCHEMBL15705506 0.69 — —
SCHEMBL15705489 0.68 ATM (0.31) —
SCHEMBL13931726 0.68 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11813267-B2 DNA-PK inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-11-14 — — US disclosed
US-8426440-B2 Indolymaleimide derivatives NOVARTIS AG (CH) 2013-04-23 — — US disclosed
Send feedback